Smruti K. Patel · FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits
Follow
Article1 min read·Published Jan 2022Older

FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2022 · 1 min read

In brief

In brief

FOXR2, a testis-restricted transcription factor, is aberrantly activated through promoter hypomethylation in 8% of tumors across 70% of cancer types. The study demonstrates FOXR2 functions as a pan-cancer oncogene by hijacking ETS transcriptional circuits to promote tumor growth in both adult and pediatric malignancies.

Written by the GCMD Library team from the article.

Smruti K. Patel

Unlabelled: Forkhead box R2 (FOXR2) is a forkhead transcription factor located on the X chromosome whose expression is normally restricted to the testis. In this study, we performed a pan-cancer analysis of FOXR2 activation across more than 10,000 adult and pediatric cancer samples and found FOXR2 to be aberrantly upregulated in 70% of all cancer types and 8% of all individual tumors. The majority of tumors (78%) aberrantly expressed FOXR2 through a previously undescribed epigenetic mechanism that involves hypomethylation of a novel promoter, which was functionally validated as necessary for FOXR2 expression and proliferation in FOXR2-expressing cancer cells. FOXR2 promoted tumor growth across multiple cancer lineages and co-opted ETS family transcription circuits across cancers. Taken together, this study identifies FOXR2 as a potent and ubiquitous oncogene that is epigenetically activated across the majority of human cancers. The identification of hijacking of ETS transcription circuits by FOXR2 extends the mechanisms known to active ETS transcription factors and highlights how transcription factor families cooperate to enhance tumorigenesis. Significance: This work identifies a novel promoter that drives aberrant FOXR2 expression and delineates FOXR2 as a pan-cancer oncogene that specifically activates ETS transcriptional circuits across human cancers. See related commentary by Liu and Northcott, p. 2977.

Statements in this article

  1. FOXR2 expression is normally restricted to the testis.

    Established
  2. FOXR2 is aberrantly upregulated in 70% of all cancer types across more than 10,000 adult and pediatric cancer samples.

    Research
  3. FOXR2 is aberrantly upregulated in 8% of all individual tumors.

    Research
  4. 78% of tumors aberrantly express FOXR2 through hypomethylation of a novel promoter.

    Research
  5. The novel promoter is necessary for FOXR2 expression and proliferation in FOXR2-expressing cancer cells.

    Research
  6. FOXR2 promotes tumor growth across multiple cancer lineages.

    Research
  7. FOXR2 co-opts ETS family transcription circuits across cancers.

    Research

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
Only a few other public items share this field — go deeper there →
GCMD Library — educational content from recorded physician discussions, not medical advice.